Rieko Shiozawa

Japanese Red Cross Society, Japan

Papers

1

Total Citations

18

H-Index

1

About

Rieko Shiozawa is a leading figure in molecular diagnostics, with a career dedicated to advancing the detection and management of viral hepatitis. Her primary research focuses on developing high-throughput, automated systems for nucleic acid testing, particularly for hepatitis B virus (HBV) and hepatitis C virus (HCV). Her most influential work, a 2002 study with 18 citations, pioneered a groundbreaking method that combined a nucleic acid purification robot with real-time detection PCR. This integrated system dramatically improved the speed, accuracy, and scalability of viral load testing. Shiozawa’s contribution was pivotal in transforming posttransfusion hepatitis screening, enabling the rapid and reliable analysis of donor blood to prevent transmission. By automating the extraction and amplification process, she helped set new standards for clinical virology labs, reducing manual error and turnaround times. Her work remains a cornerstone for modern molecular diagnostics, directly influencing protocols for blood safety and chronic hepatitis management. Shiozawa’s legacy lies in bridging robotics and real-time PCR, a synergy that continues to underpin high-throughput viral detection systems worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
High‐throughput HBV DNA and HCV RNA detection system using a nucleic acid purification robot and real‐time detection PCR: its application to analysis of posttransfusion hepatitis
18 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Japanese Red Cross Society, Japan

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago